Your browser doesn't support javascript.
loading
Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K-mutant advanced or metastatic melanoma.
Robert, Caroline; Flaherty, Keith; Nathan, Paul; Hersey, Peter; Garbe, Claus; Milhem, Mohammed; Demidov, Lev; Mohr, Peter; Hassel, Jessica C; Rutkowski, Piotr; Dummer, Reinhard; Utikal, Jochen; Kiecker, Felix; Larkin, James; D'Amelio, Anthony; Mookerjee, Bijoyesh; Schadendorf, Dirk.
Affiliation
  • Robert C; Department of Dermatology, Institut Gustave Roussy, Villejuif, France. Electronic address: Caroline.ROBERT@gustaveroussy.fr.
  • Flaherty K; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Nathan P; Mount Vernon Cancer Centre, Northwood, United Kingdom.
  • Hersey P; University of Sydney, Sydney, Australia.
  • Garbe C; University Medical Center, Tübingen, Germany.
  • Milhem M; University of Iowa Hospital and Clinics, Iowa City, IA, USA.
  • Demidov L; N. N. Blokhin Russian Cancer Research Center, Ministry of Health, Moscow, Russian Federation.
  • Mohr P; Elbe Klinikum Buxtehude, Buxtehude, Germany.
  • Hassel JC; University Hospital Heidelberg, Heidelberg, Germany.
  • Rutkowski P; Maria Sklodowska-Curie Institute Oncology Center, Warsaw, Poland.
  • Dummer R; University Hospital Zurich, Zurich, Switzerland.
  • Utikal J; German Cancer Research Center (DKFZ) and University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
  • Kiecker F; Charité-Universitätsmedizin, Berlin, Germany.
  • Larkin J; Royal Marsden Hospital, London, United Kingdom.
  • D'Amelio A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Mookerjee B; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Schadendorf D; University Hospital Essen, Essen, Germany.
Eur J Cancer ; 109: 61-69, 2019 03.
Article in En | MEDLINE | ID: mdl-30690294

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Proto-Oncogene Proteins B-raf / Melanoma / Mutation Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Proto-Oncogene Proteins B-raf / Melanoma / Mutation Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2019 Type: Article